Abstract
While numerous epidemiological studies have indicated that omega-3 polyunsaturated fatty acids have anticancer properties in various cancers, the effects and mechanisms of eicosapentaenoic acid (EPA) in ovarian cancer cell growth are poorly understood. ES2 ovarian clear cell carcinoma cells and SKOV3 adenocarcinoma cells were treated with palmitic acid or EPA, followed by flow cytometry and cell counting to measure apoptosis and proliferation, respectively. A modified protein lipid overlay assay was used to further verify whether EPA was a ligand of G protein-coupled receptor 30 (GPR30) in ES2 cells. The levels of apoptosis-related genes, phosphorylated AKT, and phosphorylated ERK1/2 were detected to explore the underlying mechanism. Finally, inhibitory effect of EPA on tumor growth via GPR30 was determined in vitro and in vivo. EPA suppressed ES2 ovarian clear cell carcinoma cells growth via GPR30, a novel EPA receptor, by inducing apoptosis. As a ligand of GPR30, EPA activated the GPR30-cAMP- protein kinase A signaling pathway. When GPR30 was suppressed by siRNA or its inhibitor G15, the antiproliferative action of EPA was impaired. Furthermore, EPA inhibited tumor growth by blocking the activation of AKT and ERK. In the mous...Continue Reading
References
Nov 27, 1999·Pharmacology & Therapeutics·D P Rose, J M Connolly
Feb 5, 2003·Biochemical and Biophysical Research Communications·Knut KotarskyBjörn Olde
Jun 24, 2003·The Journal of Antibiotics·Masatoshi TaniguchiShin-ichi Tsukamoto
Dec 3, 2003·Oncogene·Liang HuXin-Yuan Guan
May 8, 2004·Trends in Biochemical Sciences·Derek P BrazilBrian A Hemmings
Jan 26, 2007·Nature Reviews. Cancer·Robert T Dorsam, J Silvio Gutkind
Nov 6, 2007·Frontiers in Bioscience : a Journal and Virtual Library·Gabriella CastoriaFerdinando Auricchio
Apr 15, 2008·The Journal of Steroid Biochemistry and Molecular Biology·Eric R ProssnitzJeffrey B Arterburn
Dec 17, 2008·Biochemical Pharmacology·Jianguo JinSatya P Kunapuli
Apr 3, 2009·Biochemical and Biophysical Research Communications·Consuelo GajateFaustino Mollinedo
Sep 22, 2009·The Journal of Endocrinology·Marcello Maggiolini, Didier Picard
Jul 9, 2010·CA: a Cancer Journal for Clinicians·Ahmedin JemalElizabeth Ward
Jan 12, 2011·Breast Cancer Research and Treatment·Louiza S VelentzisMarie M Cantwell
Jul 21, 2011·Carcinogenesis·Haiguo SunIris J Edwards
Nov 1, 2011·Nature Medicine·Kristin M NiemanErnst Lengyel
May 25, 2012·The FEBS Journal·Claudio R Santos, Almut Schulze
Jul 31, 2012·Nature Medicine·Durba PalSamir Bhattacharya
Aug 21, 2012·Journal of Cellular Biochemistry·Masayuki FukuiBao Ting Zhu
Apr 13, 2013·Gynecologic Oncology·Lisa M LandrumJoan L Walker
Jun 14, 2013·BioMed Research International·Zhennan GuYong Q Chen
Oct 29, 2013·Chemico-biological Interactions·Li-Yuan BaiChang-Fang Chiu
Aug 29, 2014·International Journal of Molecular Sciences·Sabine HeubleinUdo Jeschke
Sep 18, 2014·The Journal of Biological Chemistry·Hiu Yee KwanZhi-Ling Yu
Oct 25, 2014·Nature Reviews. Cancer·Simran S Sabharwal, Paul T Schumacker
Dec 5, 2014·The Journal of Pharmacology and Experimental Therapeutics·Marc Q MazzucaRaouf A Khalil
Jan 28, 2015·Molecular Cancer·Yi-Jun ShuYing-Bin Liu
Mar 30, 2016·Annual Review of Nutrition·Carmen Sapienza, Jean-Pierre Issa
Feb 1, 2017·Lipids in Health and Disease·Eliot A Brinton, R Preston Mason